Skip to main content
. 2021 Nov 22;75(2):314–322. doi: 10.1093/cid/ciab970

Table 1.

Characteristics of Enrolled Participants in Clinic (n = 2055) and Community (n = 10 320) Surveys

Clinic (n = 2055) Community (n = 10 320)
Age, median (IQR), y 36 (28–48) 38 (23–58)
Female, n (%) 1580 (76.9) 7049 (68.3)
MUAC, median (IQR), cm 26.0 (25.0–26.0) 27.0 (24.0–30.0)
Previously treated for TB, n (%) 505 (24.6) 1228 (11.9)
On TB treatment at enrollment, n (%) 14 (0.7) 45 (0.4)
HIV status,a n (%)
 Negative 536 (26.1)b 7151 (69.3)
 Positive 1479 (72.0)b 3105 (30.1)
 On ART 1463 (99.0)b 2714 (87.4)
≥1 TB symptom, n (%) 131 (6.4) 1091 (10.6)
 Cough 83 (4.0) 717 (7.0)
 Loss of weight 72 (3.5) 281 (2.7)
 Night sweats 67 (3.3) 75 (0.7)
 Fever 39 (1.9) 18 (0.2)
CAD4TB score >25, n (%) 5491 (53.2)
Pregnant, n (%) Not recorded 328 (3.2)

Abbreviations: ART, antiretroviral therapy; CAD4TB, computer-aided detection for TB; HIV, human immunodeficiency virus; IQR, interquartile range; MUAC, midupper arm circumference; TB, tuberculosis.

Forty (1.9%) with missing/unknown HIV status in the clinic survey.

Self-report and clinical record review.